Strategic Advisors LLC Edwards Lifesciences Corp Transaction History

Strategic Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 03, 2022	SELL	$86.5 - $128.27 $154,143 - $228,577	-1,782 Closed	0 $0
Q4 2021 Jan 21, 2022	SELL	$106.37 - $130.68 $47,228 - $58,021	-444 Reduced 19.95%	1,782 $230,000
Q2 2021 Aug 10, 2021	BUY	$83.84 - $104.76 $186,627 - $233,195	2,226 New	2,226 $230,000
Q1 2021 May 05, 2021	SELL	$78.68 - $90.67 $186,471 - $214,887	-2,370 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$71.69 - $91.23 $10,323 - $13,137	-144 Reduced 5.73%	2,370 $211,000

Q3 2020 Oct 13, 2020	BUY	$67.19 - $87.44 $168,915 - $219,824	2,514 New	2,514 $201,000
Q4 2019 Feb 05, 2020	SELL	$71.7 - $82.09 $73,779 - $84,470	-1,029 Closed	0 $0
Q3 2019 Oct 17, 2019	BUY	$61.55 - $75.43 $63,334 - $77,617	1,029 New	1,029 $226,000

1,376

454M

3.86M

3.32M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $56.4B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Strategic Advisors LLC with notifications on news.